Purchase Order 75A50122P00023

Award Date 9/30/22
Potential Completion Date 1/31/23
Potential Value $1.2M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Austin, TX 78727, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $9,850,000.00 firm fixed price purchase order awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Luminex Corporation. The contract is to expand the use of Luminex's ARIES SARS-CoV-2 assay, which is a molecular diagnostic test for COVID-19. This award was not set aside for any specific business type. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions,...
This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Luminex Corporation is valued at $642,450.00. The contract supports the development of Luminex's ARIES SARS-CoV-2 assay under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. Special Instructions 019 revised the description for mitigating long-term effects of respiratory distress and updated submission deadlines...
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a firm fixed-price purchase order contract worth $5,389,813.00 to Luminex Corporation. The contract is for the integration of the SARS-CoV-2 virus with the NxTAG Respiratory Pathogen Panel and the submission of a 510(k) application to the U.S. Food and Drug Administration. Luminex is a manufacturer of biological testing technologies, including multiplex diagnostic solutions,...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $683,500 firm fixed price definitive contract to Luminex Corporation of Austin, Texas. The contract is for the delivery of Luminex's XMAP SARS-CoV-2 Multi-Antigen Antibody Typing Assay to support the agency's coronavirus COVID-19 response efforts. No set aside designation or major subcontractors were indicated. Luminex will provide its assay from September 2020 through July...
Luminex Corporation was awarded a $642,450 firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop an extended panel for the Luminex NXTAG COVID-19 diagnostic test. The contract is being performed in Austin, Texas over a period of four months ending July 1, 2020. This award was made under Special Instructions 019 of the department's Easy Broad Agency Announcement BAA-20-100-SOL-0002, which...
Luminex Corporation was awarded a $55,415.62 delivery order against its Multiple Award Schedule contract with the General Services Administration to provide an ARIES Two Module System for molecular testing of the Coronavirus Disease 2019 (COVID-19) to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 located in Pittsburgh, Pennsylvania. The firm fixed price order has a completion date of September 30, 2020 and was awarded on March 19, 2020 to...
This is a $36,972.00 delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain division to Luminex Corp, a foreign-owned, for-profit manufacturer of biomedical diagnostic technologies based in Austin, Texas. The contract is for the delivery of NXTAG Respiratory Pathogen Panels (RPP) and has a completion date of February 5, 2025. The contract is a firm fixed-price award without any small business set-aside designations. Luminex holds several significant federal...
Luminex Corporation was awarded a $56,087.62 firm fixed price delivery order against its Multiple Award Schedule contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10. The delivery order is for the provision of an ARIES M12V1 SYSTEM IVD instrument and installation in Austin, Texas to support the agency's COVID-19 response efforts. No set-aside designation was applied to this award made under the Veterans Health Administration's...
The National Institutes of Health's National Heart, Lung and Blood Institute awarded Lumiradx, Inc. a $243,000 firm fixed-price purchase order to finalize development of its SARS-CoV-2 and influenza A/B test. As the prime contractor, Lumiradx will deliver its LumiraDx Platform test to the NIH for use in detecting the viruses that cause COVID-19 and seasonal flu. No subcontractors or set-aside designations were identified. This purchase order supports the NIH's ongoing efforts to expand...
This is a firm fixed-price purchase order awarded by the U.S. Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base to Luminex Corporation, a foreign-owned, for-profit manufacturer of biological testing technologies headquartered in Austin, Texas. The $624,206.10 contract is for the delivery of COVID-19 LUMINEX NXTAG Respiratory Pathogens Panel Kits, which are multiplex diagnostic test kits used to detect various respiratory pathogens, including SARS-CoV-2. This...

The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded Luminex Corporation a $1.2 million firm-fixed price purchase order to complete the final stages of obtaining FDA 510(k) clearance for its proprietary ARIES Flu A/B/RSV + SARS-CoV-2 diagnostic test. Luminex will perform necessary clinical evaluations and submit the 510(k) application to achieve long-term FDA clearance of the ARIES test, which the agency considers critical to its pandemic response efforts. The work will be conducted in Austin, Texas over a four-month period concluding in January 2023. No subcontractors were identified. The original solicitation sought through a sole-source notice to have Luminex obtain FDA clearance for its ARIES diagnostic platform, as the agency determined Luminex was the only company capable of performing this work due to proprietary technology involved.

Generated 12/29/23, 3:24 PM